鲎试剂
牛血清白蛋白
化学
脂质A
溶解
抗体
微粒
色谱法
流式细胞术
脂多糖
生物化学
生物
分子生物学
免疫学
天体生物学
作者
Cristiane C. De Melo,Alexandra C. Fux,Martin Himly,Neus G. Bastús,Laura Schlahsa,Christiane Siewert,Víctor Puntes,Albert Duschl,Isabel Gessner,Jonathan A. Fauerbach
标识
DOI:10.3390/ijms241813971
摘要
Endotoxins or lipopolysaccharides (LPS), found in the outer membrane of Gram-negative bacterial cell walls, can stimulate the human innate immune system, leading to life-threatening symptoms. Therefore, regulatory limits for endotoxin content apply to injectable pharmaceuticals, and excess LPS must be removed before commercialization. The majority of available endotoxin removal systems are based on the non-specific adsorption of LPS to charged and/or hydrophobic surfaces. Albeit effective to remove endotoxins, the lack of specificity can result in the unwanted loss of essential proteins from the pharmaceutical formulation. In this work, we developed microparticles conjugated to anti-Lipid A antibodies for selective endotoxin removal. Anti-Lipid A particles were characterized using flow cytometry and microscopy techniques. These particles exhibited a depletion capacity > 6 ×103 endotoxin units/mg particles from water, as determined with two independent methods (Limulus Amebocyte Lysate test and nanoparticle tracking analysis). Additionally, we compared these particles with a non-specific endotoxin removal system in a series of formulations of increasing complexity: bovine serum albumin in water < insulin in buffer < birch pollen extracts. We demonstrated that the specific anti-Lipid A particles show a higher protein recovery without compromising their endotoxin removal capacity. Consequently, we believe that the specificity layer integrated by the anti-Lipid A antibody could be advantageous to enhance product yield.
科研通智能强力驱动
Strongly Powered by AbleSci AI